• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMET FRANCE S.A.R.L. AVANTAGE INSERT 48/22; PROSTHESIS, HIP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMET FRANCE S.A.R.L. AVANTAGE INSERT 48/22; PROSTHESIS, HIP Back to Search Results
Catalog Number P0560048
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Erythema (1840); Discharge (2225)
Event Date 01/03/2018
Event Type  Injury  
Manufacturer Narrative
(b)(4).Report source, foreign - event occurred in (b)(6).Concomitant medical products: avantage cemented shell s48, item: p0463048, lot: 0001105980; optipac-s 60 refobacin bone cement r, item: 4711500396-1, lot: a710b05615; optipac-s 60 refobacin bone cement r, item: 4711500396-1, lot: b708c05355; femoral stem 12/14, item: 00811400100, lot: 63735436; femoral head sterile 12/14, item: 00801802230 and lot: 63677745.The investigation is in progress.Once the investigation has been completed, a follow-up mdr will be submitted.
 
Event Description
It was reported that an initial left total hip arthroplasty was performed with implantation of an avantage cemented shell ø48mm, avantage inlay s48, optipac-s 60 refobacin bone cement, femoral stem 12/14 and femoral head sterile 12/14 on 17th december 2017.Subsequently, the patient experienced redness and drainage from the surgical site, was placed on prophylactic antibiotics, and was admitted for observation to rule out infection.Infection was ruled out, and the drainage discontinued without further complication.
 
Manufacturer Narrative
(b)(4).This follow-up report is being submitted to relay additional information.The following sections were updated: b5, g4, h10 during the investigation, it has been noticed that the product item p0560048 / lot 0001102705 is handled by (b)(6).The medwatch report for this product will be submitted in cmp-0559832 if any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.Zimmer biomet will continue to monitor for trends.
 
Event Description
It was reported that an initial left total hip arthroplasty was performed with implantation of an avantage cemented shell ø48mm, avantage inlay s48, optipac-s 60 refobacin bone cement, femoral stem 12/14, femoral head sterile 12/14 and intramedullary plug on 17th december 2017.Subsequently, the patient experienced redness and drainage from the surgical site, was placed on prophylactic antibiotics, and was admitted for observation to rule out infection.Infection was ruled out, and the drainage discontinued without further complication.No additional patient consequences were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AVANTAGE INSERT 48/22
Type of Device
PROSTHESIS, HIP
Manufacturer (Section D)
BIOMET FRANCE S.A.R.L.
plateau de lautagne bp75
valence cedex 26903
FR  26903
MDR Report Key8951744
MDR Text Key158711311
Report Number3006946279-2019-00378
Device Sequence Number1
Product Code LPH
UDI-Device Identifier03599870005217
UDI-Public(01)03599870005217
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 11/22/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberP0560048
Device Lot Number0001102705
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 07/31/2019
Initial Date FDA Received08/30/2019
Supplement Dates Manufacturer Received11/19/2019
Supplement Dates FDA Received11/22/2019
Is This a Reprocessed and Reused Single-Use Device? No
Removal/Correction NumberN/A
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Weight57
-
-